Impact of thrombus removal on myocardial reperfusion in patients with acute myocardial infarction treated with primary stenting  by Garcia, Eulogio et al.
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1149-17 Six-Month Results of Stenting Following Cutting 
Balloon Angioplasty in Small Coronary Arteries: A 
Randomized Comparison With Stenting Following 
Conventional Balloon Angioplasty 
Hisashi Umeda, Toru Tajika, Yosuke Murase, Toshikazu Tanaka, Hirohumi Kanda, Ken 
Sawada, Masaki Yamauchi, Hirokazu Iwata, Hitoshi Ishihara, Mitsuhiro Yokota, Mitsunori 
Iwase, Gifu Shakaihoken Hospital, Kani, Japan, Okazaki City Hospital, Okazaki, Japan. 
Background: The outcomes of patients with coronary angioplasty in small coronary 
artedes were unfavorable. Recent reports have shown that cutting balloon angioplasty 
(CBA) was achieved favorable 6-month results in small vessels, and suggested that CBA 
may cause less tissue injury and vessel stretch, producing an efficient arterial lumen 
compared to conventional balloon angioplasty (POBA). The purpose of this study was to 
evaluate 6-month outcomes of CBA followed by stenting in small coronary arteries. 
Methods: Study subjects consisted of 147 lesions of 126 patients with the reference 
diameters of target vessels <2,8 ram, who were enrolled and randomized to stenting fol- 
lowing CBA (CBA-stant: 74 lesions; 64 Pt.) or POBA (POBA-stent: 73 lesions; 62 Pt.). 
Intravascular ultrasound was performed at post-procedure and 6-month follow up. 
Results: The clinical and lesion characteristics were similar in both groups. Initial suc- 
cess rate ware similar in both groups (CBA-stent: 95%, POBA-stent: 97%). 4 lesions in 
CBA-stent crossed over 1o POBA-stent because of the inability to reach the lesion. There 
were no differences in stent type, stant size, stent length, numbers of stents, and maxi- 
mum inflalion pressure between 2 groups. 
6-month follow-up results 
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CBA-stant POBA-stent p value 
Ref. diameter (mm) 2.4±0.4 2.5±0.3 ns 
Acute gain (ram) 1.8±0.3 1.8±0.5 ns 
Late loss (mm) 0.8±0.5 1.0±0.6 0.04 
Net gain (ram) 1.0±0.5 0.8±0.7 0.06 
Neointima (ram2) 2.2±1.1 2.8±2.0 0.03 
6-month TLR (%) 13 27 0.03 
6-month MACE (%) 14 29 0.04 
TLR= target lesion revascularization; MACE= major adverse cardiac event (Death, MI, 
and TLR) 
Conclusions: 6-month results of stanting following CBA were favorable due to less 
neointimal hyperplasia, suggesting that stanting foflowing CSA were more effective in 
cases with small coronary arteries compared to conventional balloon angioplasty fol- 
lowed by stanting. 
1149-18 Effect of Baseline Thrombua in the SAFER (Saphenous 
Vein Graft Angioplasty Free of Emboll Randomized) 
Trial 
SaWendra Gid, Richard E. Kuntz, Andrew C. Eisenhauer, Jeffrey J. Popma, Ross Prpic, 
Unsel Kaya, Campbell Rogers, Donald S. Bairn, Brigham & Women's Hospital, Boston, 
Massachusetts, Harvard Clinical Research Institute, Boston, Massachusetts. 
BACKGROUND: Saphenous vein gratt (SVG) lesions with angiographic thrombus (A7) 
are at increased risk for distal embolization. METHODS: To determine the impact of AT 
on major adverse cardiac event (MACE= death, MI, or revasculadzation) and distal pro- 
tection using the PercuSurge GuardWire ~ system we evaluated patients with (n=298) 
and without (n=463) ATenrotled in the SAFER tdal using quantlfalive coronary angiogra- 
phy. RESULTS: Pts with ATwere slightly older (69±10 vs 68_+10, p---0.04), and had more 
rest angina (44.6% vs 35.3%, p<0.01 ) but had similar demographic and comorbidity pro- 
file, ATpts had larger reference vessel diameter (3.54_+0.67 vs 3.34 +-0,66, p<0.01), more 
residual % stenosis (16_+13 vs 13_+11, p=0.008) and angiographic flow-related complica- 
tions (reduced or no-reflow, 12.9% vs 5.3%, p=<0.001). This included no-reflow (9.9% vs 
3.4%, p<0.001), worsening of TIMI antegrada flow (4.2% vs 1.0%, p<0.01), distal embo- 
lization (3.6% vs 2.0%, p=0.18), and prolonged final frame-to-opeclfioation count 
(28.7+~21 vs 24.7+t4, p=0.002) compared to non-ATpts. 
AT pts had more 30-day MACE (17.4% vs 10,4%, p=0.006), death (3.0% vs 0.9%, 
p=0.04), MI (15.8% vs 9.1%, p=0.006) but similar target lesion revascularization (2.0% vs 
1.3%, p=0.55). GuardWire TM use reduced the flow-related complications in the subset of 
thrombus-laden SVG lesions (see Table).CDNCLUSlON: PCI in thrombotic SVG lesions 
had higher rates of flow-related and clinical complications, which was reduced by the use 
of PercuSurge GuardWire 1M 
Multivariate predictor Odds Ratio 95% C,I. p value 
Angiographic omplication 5.299 2.855 - 9.837 0.001 
Persistent hrombus 2.732 1.406 - 5.3111 0.001 
Lesion length(mm) 1.032 1.014- 1.050 0.01 
Final % diameter stanosis 1.019 1.001 - 1.036 0.04 
GuardWira Use 0.624 0.392 - 0.994 0.02 
1149-19 Impact of Thrombus Removal on Myocardial 
Reperfuslon in Patients With Acute Myocardial 
Infarction Treated With Primary StenUng 
EuioQio Garcia, Joseph Ludwig, Raul Moreno, Leopo]do Perez Isla, Alicia Barrio, Manuel 
Abey~ua, Javier Soriano, Carlos Crespo, Amalia Mota, Marina Paz, Hospital Gregorio 
Maranon, Madrid, Spain. 
Final TIMI flow is clearly correlated with outcome in patients with AIM who undergo 
mechanical reperfusion. Nevertheless, full epicardial flow does not necessarily correlates 
with appropiate myocardial reparfusion. Angiographic suggestion of addecuate myocar- 
dial reperfusion is being looked as one of the most appropiate markers of effective treat- 
ment and dessirable clinical outcome. 
In order to determine the influence of tbrombus removal to obtain adequate myocardial 
raperfusion, we have analised the influence of TIMI 3 flow ad myocardial blush score in 
50 patients with AMI of less than 6 hours from the onset of symptoms (cardiogehic shock 
excluded) and who underwent mechanical reperfusion with the use of the X-Sixar device 
followed bu stent implantationl These results were compared with those of 200 matched 
by infarct size and clinical profile who underwent mechanical reperfusion with stant 
implantation without prior thrombus aspiration. The quantitative angiographic analyis, 
TtMI flow and myocardial blush score are listed below. 
X-Sizer plus stent Stant p 
Pra-procadure 
RVD (mm) 3.1 (SD 0.47) 3.13 (SD 0.45) NS 
MLD (ram) 0.24 (SD 0.45) 0.26 (SD 0.43) NS 
% DS 91 (SD 14) 92 (SD 13) NS 
TIMI O-1 (%) 74 76 NS 
Post-procedure 
RVD (mm) 3.21 (SD 0.43) 3.32 (SD 0.47) NS 
MLD (mm) 2,74 (SD 0.45) 2.76 (SD 0.52) NS 
% DS 14.5 (SD 7.8) 13 (SD 8.5) NS 
TtMt 3 (%) 97 95,4 NS 
Myocardial blush 3 (%) 55 28 <0.01 
Conclusion: Compared to stent implantation, thmmbus aspiration followed by stent in 
patients with AMI is associated with similar classical angiographic results and TIMI 3 
flow, but better myocardial blush 3 score, that suggests more adequate myocardial perfu- 
sion. 
1149-20 How Rapidly and Durably Are Platelets Inhibited by a 
300 mg Clopidogrel  Loading Dose Given at the Time of 
Intervention Compared to Loading Before Intervention? 
Paul A. Gurbel. Alex I, Malinin, Kevin P. Callahan, Michele J. Buczkowski, Victor L. 
Serebruany, Sinai Hospital, Baltimore, Maq/land. 
BACKGROUND: The affect of a 300 mg loading dose of ctopidogrel administered in the 
catheterization laboratory at the time of coronary slanting versus pretreatment on the 
kinetics of platelet inhibition is unknown.METHODS: Patients undergoing elective stant- 
ing (n=103) were treated with either 300 mg clopidogrel at the time of the procedure (TP) 
or at 3-6 (3-6 pre) or 24 hours (24 pre) prior to the procedure. Platelet-rich plasma aggre- 
gation (PPA) (5p mol ADP), and flow eytometry of platelet receptors were serially per- 
formed. All patients received 325 mg aspirin and 75 mg clopidogrel daily post procedure. 
GP lib/Ilia inhibitors were not used. RESULTS: PPA was most inhibited at 2 and 24 
hours post-stanting by loading 24 hours prior to the procedure (p<.05) (see table). PAC-1 
(mean fluorescence intensity) was mildly reduced by clopidogrel (78 ± 46, baseline, 62 + 
40, day 5, p<0.05). No effect was seen on platelet-leukocyte aggregate formation.CON- 
CLUSION: Pretreatment with 300 mg clopidogre124 hours prior to intervention gives the 
best early post procedure inhibition of ADP-induced platelet aggregation. Loading with 
clopidogrel followed by 75 mg daily mildly reduces activation of GPIIb/llla but does not 
affect the formation of platelet-leukocyte aggregates. 
PPA (%Inhibition) 
Time of assessment TP 3-6 pre 24 pre 
2h post 14± 4 18_+ 7 35+ 15" 
24 h post 35-+ 11 33 + _ 16 47-+ 23" 
5d post 31± 13 41-+ 12 41-+ 14 
* p<.05 compared to TP and 3 - 6 pre 
1149-21 In-Viva Evaluation of s Novel ePTFE-Covered Self- 
Expanding Stent for  the Treatment of Diseased 
Saphenous Vein Bypass Grafts 
Steohen Oestade. Charles Davidsen, Richard Kuntz, Craig Nordhausen, Michael 
Vonash, Mark UIm, Nicholas Macd, Massachusetts General Hospital, Boston, 
Massachusetts. 
Background: There has been continued interest in covered stents for use in degenerative 
saphenous vein grafts (SVGs), but restenosis rates have been less than ideal. We evalu- 
ated long, ePTFE-covared, self-expanding stents in a porcine model. 
Methods: 80 devices (45mm-long; 4, 4.5 or 5ram-diameter) were implanted bilaterally in 
the common carotid (CCA) and internal mammary artedes (IMA) of 22 miniswine. Typi- 
cally, 4mm devices were implanted in the IMA and 5ram devices in the CCA. Device 
